7Baggers
Quarterly
Annual
    Unit: USD2025-03-29 2024-12-28 2024-09-28 2024-06-29 2024-03-30 2023-12-30 2023-09-30 2023-07-01 2023-04-01 2022-12-31 2022-09-24 2022-06-25 2022-03-26 2021-12-25 2021-09-25 2021-06-26 2021-03-27 2020-12-26 2020-09-26 2020-06-27 2020-03-28 2019-12-28 2019-09-28 2019-06-29 2019-03-30 2018-12-29 2018-09-29 2018-06-30 2018-03-31 2017-12-30 2017-09-30 2017-07-01 2017-04-01 2016-12-31 2016-09-24 2016-06-25 2016-03-26 2015-12-26 2015-09-26 2015-06-27 2015-03-28 2014-12-27 2014-09-27 2014-06-28 2014-03-29 2013-12-28 2013-09-28 2013-06-29 2013-03-30 2012-12-29 2012-09-29 2012-06-23 2012-03-24 2011-12-24 2011-09-24 2011-06-25 2011-03-26 2010-12-25 2010-09-25 2010-06-26 2010-03-27 2009-12-26 2009-09-26 2009-06-27 2009-03-28 2008-12-27 2008-09-27 2008-06-28 2008-03-29 2007-12-29 2007-09-29 2007-06-30 2007-03-31 2006-12-30 2006-09-30 2006-06-24 2006-03-25 2005-12-24 2005-09-24 2005-06-25 2005-03-26 2004-12-25 2004-09-25 2004-06-26 2004-03-27 2003-12-27 2003-09-27 2003-06-28 
      
    		                                                                                        
      operating activities
    		                                                                                        
      net income
    		-17,400,000 201,000,000 178,600,000 194,500,000 169,900,000 246,500,000 90,600,000 -40,500,000 218,500,000 187,400,000 118,700,000 228,400,000 455,700,000 499,200,000 328,800,000 268,100,000 619,400,000 653,400,000 493,600,000 136,200,000 94,900,000 385,800,000 -123,500,000 93,900,000 -272,600,000 98,600,000 50,500,000 112,900,000 -681,400,000 406,700,000 82,700,000 59,500,000 526,800,000 86,500,000 92,100,000 84,900,000 68,900,000 84,900,000 25,100,000 29,500,000 47,800,000 29,200,000 28,100,000 11,316,000 -16,765,000 -5,351,000 -1,113,902,000 -10,950,000 -51,104,000 3,118,000 -77,767,000 23,594,000 -40,273,000 20,812,000 27,569,000 36,196,000 82,445,000 10,940,000 -136,974,000 27,448,000 20,618,000 26,095,000 34,940,000 41,000,000 -2,300,170,000 47,993,000 -144,373,000 61,378,000 55,986,000 -358,608,000 32,110,000 24,748,000 21,634,000 16,086,000 -1,474,000 12,017,000 11,164,000 5,716,000 9,476,000 8,158,000 6,048,000 4,574,000 5,210,000 3,325,000 2,589,000 1,040,000 2,334,000 1,077,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                                                                                        
      depreciation
    		24,100,000 23,300,000 24,100,000 22,600,000 23,000,000 29,600,000 22,900,000 22,400,000 21,600,000 22,700,000 22,000,000 22,300,000 22,600,000 22,300,000 23,800,000 22,700,000 20,400,000 21,100,000 20,300,000 20,500,000 20,700,000 21,600,000 22,800,000 22,900,000 23,100,000 23,700,000 23,800,000 25,800,000 25,000,000 27,000,000 26,100,000 24,000,000 19,100,000 20,400,000 21,000,000 21,100,000 20,300,000 19,900,000 20,700,000 20,100,000 20,400,000 20,300,000 22,000,000 23,702,000 24,061,000 24,937,000 25,013,000 24,287,000 21,876,000 24,342,000 23,744,000 15,926,000 16,071,000 16,110,000 17,908,000 17,482,000 16,694,000 16,862,000 17,437,000 17,439,000 16,695,000 16,892,000 18,544,000 17,258,000 15,596,000 15,797,000 13,782,000 14,270,000 14,202,000 10,159,000 3,709,000 3,547,000 3,414,000 3,621,000 3,814,000 2,246,000 1,768,000 1,664,000 1,648,000 1,641,000 1,520,000 1,612,000 1,451,000 1,399,000 1,373,000 1,489,000 1,418,000 1,513,000 
      amortization of acquired intangible assets
    		52,100,000 50,700,000 50,500,000 49,700,000 50,700,000 58,800,000 52,600,000 58,800,000 59,200,000 63,200,000                                                                               
      stock-based compensation expense
    		28,400,000 30,100,000 13,200,000 14,600,000 25,800,000 28,700,000 19,000,000 16,900,000 23,200,000 20,500,000 14,900,000 15,300,000 17,800,000 18,700,000 14,000,000 15,400,000 17,000,000 18,600,000 29,600,000 19,900,000 15,700,000 18,100,000 13,500,000 13,900,000 17,500,000 17,100,000 11,900,000 17,200,000 19,500,000 16,400,000 14,800,000 14,400,000 19,800,000 19,200,000 20,300,000 14,500,000 14,700,000 15,900,000 17,100,000 16,400,000 13,700,000 12,100,000 10,900,000 13,002,000 12,372,000 13,726,000 10,409,000 10,819,000 19,013,000 12,066,000 14,212,000 8,754,000 8,949,000 8,657,000 8,227,000 7,779,000 8,768,000 10,698,000 9,636,000 7,949,000 8,454,000 8,121,000 8,586,000 8,010,000 8,873,000 7,470,000 5,696,000 6,542,000 4,903,000 7,192,000 1,413,000 1,587,000 1,588,000 1,516,000               
      deferred income taxes
    		-62,700,000 -19,500,000  -5,500,000 -29,200,000 -17,600,000  -38,600,000 -35,400,000 -26,200,000  -18,700,000 -19,600,000 -21,900,000  -20,800,000 -11,500,000 -12,000,000  -19,100,000 283,700,000 -327,900,000  -21,500,000 -123,300,000 -50,000,000  -36,700,000 -42,900,000 -390,700,000  -42,000,000 -238,000,000 -24,600,000 -51,600,000 -39,500,000 -36,700,000 -28,000,000 -37,900,000 -31,800,000 -48,600,000 -30,500,000 -38,500,000 -39,812,000 -39,729,000 -125,059,000 -78,592,000 -26,889,000 -22,379,000 -70,123,000 -30,939,000 -21,165,000 -89,982,000 -13,106,000 -12,761,000 -31,908,000 16,377,000 -19,815,000 -73,422,000 -4,067,000 -36,129,000 -8,108,000 -4,738,000 3,697,000 -1,615,000 715,000 10,432,000 1,901,000 -2,696,000 -20,002,000 -11,028,000 21,000 15,887,000 993,000 -4,333,000 7,000 -1,000 -1,470,000           
      intangible asset impairment charges
    		                     30,200,000                                                                   
      other adjustments and non-cash items
    		20,400,000 -19,100,000 13,500,000 9,400,000 -4,500,000 27,500,000 -1,700,000 1,000,000 500,000 29,100,000 -3,700,000 17,600,000 13,000,000 5,700,000 4,500,000 900,000 -10,600,000 29,500,000 3,700,000 8,800,000 14,300,000 500,000 6,200,000 5,900,000 -900,000 6,900,000 1,900,000 -500,000 6,100,000 1,200,000 7,000,000 4,100,000 3,700,000 -6,000,000 -4,100,000 200,000 2,500,000 -1,500,000                                                   
      changes in operating assets and liabilities, excluding the effect of acquisitions and dispositions:
    		                                                                                        
      accounts receivable
    		-3,700,000 -41,700,000 43,500,000 17,600,000 18,100,000 -38,200,000 49,500,000 30,800,000 -36,800,000 -45,000,000 78,400,000 92,300,000 149,700,000 -48,100,000 -600,000 282,900,000 4,100,000 -175,500,000 -296,600,000 -130,200,000 -17,900,000 17,600,000 -66,800,000 -28,300,000 18,200,000 400,000 -24,400,000 -16,300,000 8,900,000 -6,400,000 -11,800,000 -57,700,000 6,500,000 21,500,000 -21,000,000 -3,800,000 -11,300,000 4,300,000 -33,800,000 200,000 13,000,000 -9,700,000 -20,500,000 6,856,000 5,990,000 15,554,000 -5,209,000 684,000 1,724,000 6,903,000 11,050,000 -14,482,000 -957,000 -6,616,000 -29,251,000 11,773,000 -6,118,000 6,465,000 -15,498,000 2,374,000 -7,750,000 663,000 18,431,000 22,426,000 11,462,000 5,262,000 -4,327,000 483,000 -22,615,000 -21,977,000 -17,435,000 -13,550,000 -9,409,000 1,124,000 1,699,000 1,837,000 -8,652,000 -4,429,000 -3,692,000 -1,554,000 -674,000 -3,390,000 -635,000 -5,408,000 4,995,000 -3,387,000 -3,383,000 1,831,000 
      inventories
    		-5,700,000 -36,100,000  -16,700,000 -17,400,000 -13,000,000  7,600,000 -9,100,000 -47,000,000  -60,400,000 -9,000,000 -17,400,000  -36,400,000 -24,800,000 -21,200,000  -14,700,000 -18,400,000 -14,900,000 18,700,000 -27,700,000 -26,100,000 -27,900,000 -11,300,000 -11,800,000 -4,200,000 -23,300,000 8,600,000 8,800,000 -8,300,000 -20,700,000 5,500,000 4,400,000 1,300,000 -3,600,000 11,000,000 3,900,000 10,300,000 18,700,000 -2,500,000 -18,373,000 -9,676,000 -14,151,000 13,105,000 15,779,000 2,285,000 -6,004,000 -3,215,000 2,930,000 -415,000 -11,474,000 2,573,000 -10,010,000 -12,025,000 -12,696,000 5,975,000 3,686,000 -2,939,000 -11,969,000 736,000 -6,712,000 -459,000 -8,707,000 8,420,000 -20,044,000 -7,204,000 -10,767,000 -10,106,000 68,000 6,689,000 -4,648,000 882,000 -7,543,000 -11,368,000 -4,994,000 -2,846,000 -4,732,000 -2,387,000 5,584,000 2,805,000 -543,000 1,328,000 -162,000 3,111,000 -1,009,000 
      prepaid income taxes
    		-36,400,000 29,200,000 52,200,000 41,400,000 -45,200,000 -70,100,000 2,100,000 7,000,000 -9,600,000 17,900,000 -12,800,000 -4,100,000 -1,800,000 -4,600,000 37,300,000 22,300,000 -55,500,000 8,900,000 6,800,000 17,100,000 -28,700,000 1,000,000 8,300,000 -3,200,000 -10,300,000 2,000,000 12,500,000 7,900,000 -37,900,000 8,100,000 -4,200,000 -4,900,000 1,200,000 -800,000 2,800,000 -1,500,000 -18,300,000 21,700,000 2,000,000 -2,600,000 -21,100,000 22,400,000 -12,000,000 -10,345,000 0 44,745,000 -11,878,000 53,678,000 -35,238,000 18,538,000 5,711,000 36,000 -16,000 340,000 -10,098,000 12,792,000   3,483,000    4,053,000 5,785,000                         
      prepaid expenses and other assets
    		-4,400,000 13,200,000 11,500,000 8,300,000 -15,100,000 2,600,000 -1,000,000 14,100,000 -15,700,000 26,200,000 6,000,000 23,000,000 355,000,000 300,000 -34,000,000 14,400,000 -18,400,000 -18,300,000 3,800,000 27,600,000 -315,000,000 -2,600,000 5,800,000 -1,400,000 -8,600,000 -1,800,000 -4,500,000 9,400,000 -4,100,000 -5,000,000 2,000,000 -400,000 13,400,000 -17,400,000 11,300,000 -1,200,000 -7,300,000 -7,700,000 1,000,000 7,300,000 400,000 -3,000,000 3,500,000 4,031,000 7,662,000 2,107,000 -4,423,000 4,069,000 2,402,000 -1,177,000 68,450,000 4,930,000 -3,044,000 -530,000 -1,829,000 1,543,000   -691,000    -2,783,000 851,000                         
      accounts payable
    		-31,000,000 36,200,000 -4,300,000 -200,000 19,500,000 7,200,000 -2,700,000 -7,100,000 -14,700,000 1,500,000 -16,900,000 -6,600,000 22,900,000 -13,800,000 11,000,000 -23,400,000 28,200,000 4,600,000 50,200,000 -7,200,000 7,500,000 -55,400,000 25,400,000 -3,700,000 -11,200,000 -16,000,000 23,500,000 9,900,000 -2,400,000 -7,100,000 17,700,000 -28,800,000 18,300,000 -17,800,000 25,700,000 12,800,000 6,500,000 -4,900,000 27,300,000 16,000,000 7,000,000 -24,800,000 10,100,000 14,017,000 -22,740,000 10,423,000 8,010,000 -1,477,000 -2,310,000 -10,629,000 11,923,000 -10,494,000 2,838,000 -499,000 10,950,000 -10,932,000 -4,057,000 6,628,000 1,087,000 2,937,000 985,000 2,142,000 -3,247,000 -2,245,000 -1,922,000 -5,467,000 -1,054,000 -3,718,000 -1,712,000 -3,705,000 4,212,000 1,748,000 5,443,000 2,862,000 -8,560,000 6,560,000 2,496,000 3,444,000 -1,578,000 2,835,000 3,267,000 -901,000 -351,000 1,438,000 -1,966,000 427,000 142,000 -233,000 
      accrued expenses and other liabilities
    		-39,100,000 -54,600,000 14,900,000 45,200,000 49,000,000 -35,700,000 -24,900,000 33,100,000 -23,200,000 800,000 7,200,000 -25,900,000 -39,500,000 42,400,000 22,700,000 22,500,000 -108,200,000 58,100,000 55,500,000 91,300,000 -28,200,000 -22,600,000 31,400,000 23,300,000 -19,600,000 -51,600,000 62,400,000 13,900,000 -71,400,000 48,900,000 -33,200,000 -536,500,000 537,300,000 14,600,000 10,900,000 36,800,000 7,700,000 -9,800,000 11,600,000 44,600,000 -14,300,000 -5,000,000 -1,400,000 22,611,000 -60,178,000 53,667,000 -29,765,000 43,899,000 -87,937,000 76,138,000 -81,247,000 -10,209,000 39,133,000 11,306,000 31,021,000 10,508,000 -2,362,000 1,402,000 7,235,000 -17,042,000 7,304,000 2,155,000 15,482,000 1,590,000                         
      deferred revenue
    		23,900,000 -23,400,000 -10,600,000 11,200,000 19,300,000 -10,600,000 -31,600,000 3,500,000 40,200,000 2,300,000 -9,900,000 -9,300,000 11,900,000 -5,000,000 -8,600,000 15,800,000 17,300,000 -10,500,000 9,500,000 -300,000 16,100,000 -10,300,000 10,500,000 -4,800,000 5,400,000 3,300,000 -5,200,000 5,700,000 8,600,000 -10,600,000 -11,400,000 19,000,000 -3,700,000 -14,500,000 1,300,000 6,200,000 -7,200,000 -5,200,000 13,700,000 -4,900,000 8,500,000 -1,200,000 4,400,000 1,615,000 6,525,000 2,560,000 7,119,000 1,898,000 10,551,000 -6,243,000 1,516,000 5,586,000 1,818,000 3,813,000 -3,564,000 -5,081,000 6,851,000 1,313,000 848,000 -279,000 11,123,000 9,581,000 5,244,000 1,882,000 3,066,000 9,448,000 4,985,000 7,329,000 6,944,000 7,764,000 2,973,000 6,645,000 3,432,000 1,469,000 5,799,000 2,237,000 1,331,000 1,163,000 3,945,000 798,000 3,479,000 -83,000 647,000 503,000 445,000 1,927,000 691,000 296,000 
      net cash from operating activities
    		169,400,000 189,300,000 367,000,000 405,800,000 292,400,000 220,000,000 258,700,000 332,800,000 206,300,000 253,400,000 168,600,000 330,700,000 1,062,200,000 564,200,000 465,400,000 662,800,000 552,200,000 650,000,000 442,000,000 223,000,000 117,700,000 113,900,000 247,700,000 163,700,000 133,500,000 104,600,000 232,400,000 234,000,000 97,400,000 169,100,000 166,600,000 -411,700,000 83,800,000 169,600,000 226,700,000 246,100,000 150,100,000 164,300,000 232,500,000 242,300,000 157,800,000 153,500,000 131,700,000 158,385,000 69,049,000 149,266,000 77,998,000 246,296,000 14,503,000 155,025,000 85,591,000 71,796,000 101,104,000 111,731,000 118,909,000 119,924,000 81,870,000 135,321,000 118,771,000 117,842,000 94,122,000 125,977,000 150,741,000 154,473,000 120,264,000 120,887,000 89,995,000 106,570,000 118,301,000 49,730,000 49,214,000 23,818,000 49,075,000 31,143,000 1,725,000 26,320,000 1,474,000 1,605,000 11,115,000 10,713,000 17,280,000 5,265,000 13,038,000 1,548,000 10,508,000 788,000 4,678,000 10,062,000 
      investing activities
    		                                                                                        
      acquisition of business, net of cash acquired
    		                                                       -72,072,000                                 
      acquisition of intangible assets
    		0 -15,400,000                                                                                       
      sale of business, net of cash disposed
    		  0 0 0 -31,300,000                                                                                   
      capital expenditures
    		-15,500,000 -16,800,000 -16,400,000 -20,500,000 -12,800,000 -22,700,000 -36,300,000 -21,000,000 -18,700,000 -15,800,000  -14,700,000 -36,900,000 800,000  -19,500,000 -19,300,000 -32,400,000  -23,600,000 -18,200,000 -11,400,000  -14,800,000 -13,500,000 -9,500,000  -13,300,000 -14,400,000 -10,200,000                                                           
      free cash flows
    		153,900,000 172,500,000 350,600,000 385,300,000 279,600,000 197,300,000 222,400,000 311,800,000 187,600,000 237,600,000  316,000,000 1,025,300,000 565,000,000  643,300,000 532,900,000 617,600,000  199,400,000 99,500,000 102,500,000  148,900,000 120,000,000 95,100,000  220,700,000 83,000,000 158,900,000                                                           
      increase in equipment under customer usage agreements
    		-24,700,000 -14,800,000 -13,900,000 -13,400,000 -15,200,000 -15,300,000 -16,200,000 -15,500,000 -13,400,000 -13,300,000 -11,800,000 -11,000,000 -16,800,000 -17,000,000 -16,000,000 -15,600,000 -15,400,000 -12,400,000 -13,200,000 -11,400,000 -13,400,000 -20,100,000 -12,200,000 -11,000,000 -15,800,000 -13,100,000 -11,600,000 -11,400,000 -12,600,000 -11,600,000 -11,600,000 -12,900,000 -12,100,000 -13,200,000 -11,400,000 -13,500,000 -11,700,000 -10,600,000 -11,100,000 -10,500,000 -9,400,000 -10,300,000 -9,000,000 -8,936,000 -9,996,000 -7,968,000 -9,265,000 -10,956,000 -9,741,000 -11,214,000 -12,874,000 -13,425,000 -11,439,000 -7,886,000 -7,237,000 -7,610,000 -7,333,000 -5,698,000 -3,987,000 -4,884,000 -5,265,000 -4,512,000 -5,432,000 -6,687,000 -6,703,000 -3,964,000 -7,149,000 -6,711,000 -6,269,000 -4,854,000                   
      strategic investments
    		-9,000,000 -6,000,000 0 -3,000,000                                                                                     
      maturities of available-for-sale securities
    		48,000,000 32,000,000                                                                                       
      other activity
    		-600,000 -700,000 -400,000 4,300,000 -5,500,000 -400,000 -300,000 -400,000 -4,800,000 -1,900,000 -500,000 -200,000   -100,000 -1,600,000 -300,000 -200,000 0 -1,300,000   -1,600,000 -1,700,000 -2,100,000 -1,500,000 -3,300,000 -1,700,000 -1,800,000 -400,000                                                           
      net cash from investing activities
    		-324,300,000 -22,000,000 -595,700,000 -42,600,000 -38,500,000 -104,200,000 -56,000,000 -38,700,000 -16,400,000 -41,000,000 -32,100,000 -9,800,000 9,100,000 -173,500,000 -43,100,000 -758,400,000 -478,200,000 -49,900,000 -137,900,000 -36,300,000 78,300,000 -45,700,000 -80,800,000 -32,800,000 -36,400,000 -130,700,000 -107,500,000 -26,400,000 -35,100,000 -26,200,000 -107,800,000 -30,200,000 449,000,000 -25,200,000 -32,300,000 -21,600,000 -26,800,000 12,300,000 -29,300,000 -17,800,000 -17,000,000 -22,000,000 -15,100,000 -17,331,000 -20,186,000 -14,383,000 -21,333,000 -26,018,000 50,353,000 15,752,000 -3,798,860,000 -20,834,000 -6,489,000 -24,601,000 -20,914,000 -86,927,000 -122,414,000 -36,332,000 -96,923,000 -11,071,000 56,290,000 -15,276,000 -10,209,000 -18,268,000 -15,533,000 -17,509,000 -610,160,000 -14,714,000 21,429,000 -2,076,855,000 -48,657,000 874,000 -1,303,000 -10,140,000 -146,482,000 -25,196,000 -3,308,000 -31,690,000 -1,127,000 -7,186,000 -2,064,000 -3,117,000 -2,103,000 -1,544,000 -1,587,000 -1,387,000 -784,000 -1,800,000 
      financing activities
    		                                                                                        
      repayment of long-term debt
    		-9,400,000 -9,400,000 -9,400,000 -9,300,000 -9,400,000 -259,400,000 -3,700,000 -3,800,000 -3,700,000 -3,800,000 0 0 0 -1,387,500,000 -18,700,000 -18,800,000 -18,700,000 -18,800,000 -9,400,000 -9,300,000 -9,400,000 -9,400,000 0 0 0 -1,462,500,000 -9,400,000 -9,400,000 -9,300,000 -1,331,300,000 -28,100,000 -18,800,000 -18,700,000 -18,800,000 -18,800,000 -18,700,000 -18,700,000 -18,800,000 -1,050,000,000 -1,687,500,000 -28,700,000 -328,800,000 -16,200,000 -16,300,000 -41,250,000 -521,250,000  -16,250,000 -16,250,000 -16,250,000                                       
      payment of contingent consideration
    		  0 0   0 0   0 0                                   -525,000 0 -39,025,000 -3,408,000   -47,575,000 -4,105,000 1,000 15,365,000 0 -19,660,000                               
      repurchases of common stock
    		-200,000,000 -517,300,000 -58,300,000 -100,000,000 0 -676,800,000 -211,200,000 -113,600,000 -50,000,000 -100,000,000 -175,100,000 0                                                                             
      proceeds from issuance of common stock pursuant to employee stock plans
    		8,700,000 12,200,000  6,800,000 8,900,000 9,500,000  9,300,000 13,300,000 15,100,000  9,600,000 10,900,000 6,400,000  6,000,000 10,300,000 23,300,000  18,100,000 17,900,000 18,700,000  7,100,000 15,300,000 13,500,000  7,800,000 6,800,000 9,500,000                                                           
      payment of minimum tax withholdings on net share settlements of equity awards
    		-200,000 -21,700,000 -800,000 -300,000 -100,000 -16,200,000 -300,000 -500,000 -200,000 -23,000,000 -300,000 -100,000 -100,000 -22,400,000 -600,000 -200,000 -300,000 -46,400,000 -1,700,000 -100,000 -1,600,000 -10,900,000 -400,000 -500,000 -300,000 -11,600,000 -600,000 -500,000 -1,300,000 -14,300,000 -400,000 -1,700,000 -1,200,000 -16,400,000 -300,000 -500,000 -700,000 -14,900,000 -300,000 -500,000 -1,500,000 -10,600,000 -600,000 -37,000                                             
      payments under finance lease obligations
    		-800,000 -800,000 -900,000 -1,000,000 -1,000,000 -900,000 -700,000 -1,000,000 -1,300,000 -1,000,000 -1,000,000 -1,100,000 -1,100,000 -600,000 -900,000 -600,000 -400,000 -500,000 -500,000 -400,000 -400,000 -400,000                                                                   
      net cash from financing activities
    		-201,700,000 -537,000,000 -56,800,000 -103,800,000 -4,200,000 -943,800,000 -210,600,000 -109,600,000 -49,500,000 -113,500,000 -169,800,000 -240,200,000 -202,500,000 -143,500,000 -82,000,000 109,600,000 -129,200,000 -428,200,000 -350,900,000 -241,700,000 222,600,000 -289,900,000 9,200,000 -104,500,000 -8,000,000 -328,200,000 -27,900,000 -241,500,000 -115,100,000 -20,300,000 -110,600,000 -113,100,000 -45,100,000 -40,400,000 -87,500,000 -98,600,000 -458,000,000 -15,600,000 -593,200,000 -11,200,000 -11,100,000 -321,200,000 -10,700,000 6,822,000 -6,783,000 -514,439,000 -193,425,000 -5,481,000 -37,283,000 -12,581,000 3,367,862,000 363,000 -33,812,000 -6,314,000 1,359,000 7,387,000 5,007,000 -6,079,000 1,179,000 -46,003,000 -63,937,000 -58,814,000 -92,262,000 -108,853,000 -58,640,000 -28,869,000 495,226,000 -69,543,000   7,000,000 14,543,000 -30,745,000 -13,258,000 63,513,000 831,000 15,578,000 10,677,000 1,774,000 3,372,000 8,000,000 1,775,000 438,000 820,000 1,760,000 902,000 1,327,000 233,000 
      effect of exchange rate changes on cash and cash equivalents
    		4,000,000 -8,400,000 6,600,000 -300,000 -1,800,000 4,400,000 -1,400,000 -1,700,000 500,000 2,900,000 -2,500,000 3,800,000 1,200,000 3,300,000 2,400,000 -2,800,000 2,900,000 -4,200,000 3,600,000 -600,000 -300,000 1,400,000   800,000 -1,300,000 -5,700,000 -4,900,000 2,600,000 1,200,000 4,000,000 8,800,000 900,000 -6,400,000 0 -700,000 700,000 -2,000,000 -3,700,000 1,200,000 -3,200,000 -2,400,000 -2,300,000 92,000 -46,000 -446,000 806,000 -1,349,000 -1,048,000 -155,000 755,000 -804,000 676,000 -66,000 -823,000 499,000 419,000 -499,000 1,230,000 -715,000 -202,000 -31,000 1,195,000 -859,000 -342,000 1,309,000 737,000 -253,000 -990,000 -462,000 -954,000 64,000 165,000 -359,000               
      net decrease in cash and cash equivalents
    		-352,600,000 -378,100,000                    -220,300,000                   126,500,000 -192,100,000                                            -162,000   
      cash and cash equivalents, beginning of period*
    		0 2,160,200,000 0 0 0 2,755,700,000                                                                                   
      cash and cash equivalents, end of period
    		-352,600,000 1,782,100,000  259,100,000 247,900,000 1,932,100,000  182,800,000 140,900,000 2,441,300,000 -35,800,000 84,500,000 870,000,000 1,420,800,000 342,700,000 11,200,000 -52,300,000 868,700,000 -43,200,000 -55,600,000 418,300,000 381,500,000 173,900,000 26,900,000 89,900,000 311,100,000 91,300,000 -38,800,000 -50,200,000 664,400,000 -47,800,000 -546,200,000 488,600,000 646,000,000 106,900,000 125,200,000 -334,000,000 650,300,000 -393,700,000 214,500,000 126,500,000 544,000,000 103,600,000 147,978,000 42,034,000 442,488,000  213,448,000 26,525,000 718,471,000  50,521,000 61,479,000 793,082,000  40,883,000 -35,118,000 608,036,000  60,053,000 86,273,000 345,042,000  26,493,000 45,749,000 171,479,000    154,663,000  39,299,000 17,192,000 37,309,000  1,855,000 13,771,000 94,514,000  6,556,000 22,989,000 72,702,000  811,000 11,118,000 45,015,000 5,303,000 8,453,000 
      intangible asset impairment charge
    		     4,300,000                     0 0                                                             
      acquisition of businesses, net of cash acquired
    		 -300,000         0 -200,000 -1,100,000 -157,300,000 -1,400,000 -723,300,000 -435,100,000 -4,900,000 -76,200,000 0 -31,400,000 -11,800,000 -1,200,000 -800,000 -2,000,000 -106,600,000 -72,100,000 0 -300,000 -4,100,000 -79,200,000                                                          
      deferred income taxes and other non-cash taxes
    		                                                                                        
      intangible assets and equipment impairment charges
    		      0                                                                                  
      loss on assets held-for-sale
    		                                                                                        
      contingent consideration fair value adjustments
    		                                                                                        
      debt extinguishment loss
    		          0 0   0 0 0 21,600,000            1,000,000      0    18,200,000 0 6,700,000  23,000 4,437,000 2,940,000 5,962,000 0                                         
      changes in operating assets and liabilities, excluding the effect of acquisitions:
    		                                                                                        
      inventory
    		                                                                                        
      purchases of available-for-sale securities
    		                                                                                        
      proceeds from the department of defense
    		      0 0   0 16,300,000                                                                             
      purchase of intellectual property
    		  0            0 0       0            0 0                                                     
      proceeds from long-term debt, net of issuance costs
    		          0 0 0 1,491,200,000                                                                           
      repayments under accounts receivable securitization agreement
    		                  0 0                                                                     
      repayment of acquired long-term debt
    		          0                                                                              
      payment of deferred acquisition consideration
    		      0 0 0 -800,000         0 0 -7,700,000 -16,600,000 -3,900,000                    0 -35,000                                             
      net proceeds from issuance of common stock under employee stock plans
    		                                                                                        
      net increase in cash and cash equivalents
    		  -278,900,000 259,100,000 247,900,000 -823,600,000 -9,300,000 182,800,000 140,900,000 101,800,000 -35,800,000 84,500,000 870,000,000 250,500,000 342,700,000 11,200,000 -52,300,000 167,700,000 -43,200,000 -55,600,000   173,900,000 26,900,000 89,900,000 -355,600,000 91,300,000 -38,800,000 -50,200,000 123,800,000 -47,800,000 -546,200,000 488,600,000 97,600,000 106,900,000   159,000,000 -393,700,000    103,600,000 147,968,000 42,034,000 -380,002,000 -135,954,000 213,448,000 26,525,000 158,041,000 -344,652,000 50,521,000 61,479,000 80,750,000 98,531,000 40,883,000 -35,118,000 92,411,000 24,257,000 60,053,000 86,273,000 51,856,000 49,465,000 26,493,000 45,749,000 75,818,000     6,603,000 39,299,000 17,192,000 7,386,000 -80,217,000 1,855,000 13,771,000 -19,480,000 11,747,000 6,556,000 22,989,000 4,367,000 11,391,000 811,000   5,303,000 8,453,000 
      cash and cash equivalents, end of period*
    		                                                                                        
      intangible asset and equipment impairment charges
    		                  0 0   241,600,000 0                                                                 
      contingent consideration - fair value adjustments
    		       0                                                                                 
      contingent consideration - fair value adjustment
    		                                                                                        
      purchase of strategic equity investments
    		     -34,500,000                                                                                   
      contingent consideration-fair value adjustments
    		                                                                                        
      purchase of equity investment
    		      0 0 0 -10,000,000                                                                               
      proceeds from senior notes, net of issuance costs
    		                                                                                        
      repayment of senior notes
    		              0 0 0 -970,800,000         0 0                                                             
      repayments under revolving credit line
    		                  -250,000,000                                                                      
      proceeds from accounts receivable securitization agreement
    		              0    0 0               0                                                      
      purchase of non-controlling interest
    		              0    0 -100,000 -300,000 -1,400,000                                                                   
      cash and cash equivalents, beginning of period
    		      0 0 0 2,339,500,000 0 0 0 1,170,300,000 0 0 0 701,000,000 0 0 0 601,800,000 0 0 0 666,700,000 0 0 0 540,600,000 0 0 0 548,400,000 0 0 0 491,300,000 0 0 0 736,100,000 0 10,000 0 822,490,000  0 0 560,430,000  0 0 712,332,000  0 0 515,625,000  0 0 293,186,000  0 0 95,661,000    100,403,000  0 0 29,923,000  0 0 113,994,000  0 0 68,335,000  0 0 45,177,000 0 0 
      repayment under accounts receivable securitization agreement
    		                                                                                        
      amortization
    		                              94,400,000 94,300,000 76,000,000 94,900,000 93,600,000 99,800,000 93,700,000 96,000,000 101,600,000 100,400,000 106,200,000 101,700,000 109,400,000 110,235,000 105,983,000 102,882,000 107,611,000 104,668,000 104,400,000 103,813,000 90,904,000 61,013,000 60,970,000 61,013,000 60,470,000 59,671,000 59,041,000 56,608,000 55,006,000 57,097,000 57,103,000 57,099,000 52,094,000 53,798,000 50,453,000 50,384,000 32,190,000 30,841,000 31,102,000 26,404,000 4,182,000 4,074,000 4,005,000 4,610,000 3,841,000 971,000 914,000 915,000 286,000 282,000 295,000 290,000 474,000 460,000 472,000 471,000 443,000 334,000 
      net proceeds from sale of business
    		                  -3,400,000 0                                                                     
      purchase of property and equipment
    		                              -22,000,000 -11,300,000 -13,000,000 -11,500,000 -20,300,000 -7,600,000 -10,300,000 -9,100,000 -20,200,000 -7,900,000 -9,200,000 -10,800,000 -13,400,000 -11,123,000 -11,360,000 -8,417,000 -7,838,000 -15,228,000 -14,655,000 -11,233,000 -12,457,000 -6,460,000 -7,442,000 -6,790,000 -5,891,000 -7,238,000 -7,269,000 -7,387,000 -8,324,000 -7,394,000 -6,719,000 -5,573,000 -6,548,000 -8,251,000 -7,059,000 -9,499,000 -10,898,000 -13,328,000 -16,614,000 -12,444,000 -6,082,000 -7,532,000 -3,296,000 -5,930,000 -4,613,000 -3,560,000 -1,567,000 -3,249,000           
      proceeds from revolving credit line
    		                  0 0                   183,000,000                                                  
      amortization of acquired intangibles
    		           87,100,000 83,500,000 85,700,000  78,400,000 74,800,000 71,700,000  73,100,000 73,000,000 72,800,000  90,400,000 94,500,000 95,100,000  94,700,000 94,500,000 94,200,000                                                           
      payment of acquired long-term debt
    		            0 -63,600,000      0   0 0 0 -2,500,000                                                               
      debt extinguishment losses
    		             700,000         0 0 0 800,000 0 0                                                             
      repayment under revolving credit line
    		               0 0 -250,000,000                                                                       
      repurchase of common stock
    		             -167,000,000  -188,300,000 -120,100,000 -101,300,000  100,000 -267,600,000 -80,900,000 0 -50,000,000 -3,100,000 -147,000,000 -88,500,000 -96,600,000       0 -114,100,000                                                     
      purchase of equity method investment in ssi
    		                                                                                        
      loans to ssi
    		                                                                                        
      purchase of interest rate caps
    		                      0 0   0            -7,100,000 0                                                 
      proceeds from senior notes
    		               0 0 950,000,000         0 0 1,000,000,000 350,000,000                                                           
      payment of debt issuance costs
    		               0 0 -13,700,000     0 0 0 -2,700,000 0 0 -11,600,000 -11,900,000         -14,400,000    0    -2,421,000    -73,500,000 -2,086,000   0 0 0 -5,327,000                               
      purchase of insurance contracts
    		                   0 0 -2,400,000                         0 0 0 -4,000,000     0 0 0 -5,322,000 0 0 0 -5,322,000 0 0                         
      adjustments to reconcile net income income to net cash from operating activities:
    		                                                                                        
      goodwill impairment charge
    		                          0 0                                   0 0                         
      purchase of cost-method investment
    		                      0 0   0 0                        0 -100,000 -150,000  0 51,000 -150,000  -246,000 -350,000 -125,000                           
      purchases of insurance contracts
    		                                   0                                                     
      proceeds from long-term debt
    		                      0 0 0 1,500,000,000 0 0 0 1,500,000,000                                                           
      payments to extinguish convertible notes
    		                          0 -243,400,000 -5,900,000 -296,900,000 -106,100,000 -269,100,000 -14,600,000 -6,400,000 -81,300,000 0                                                     
      payoff of acquired long-term debt
    		                                                                                        
      payments to repurchase common stock pursuant to asr agreement
    		                   0 0 -205,000,000                                                                   
      proceeds from amounts borrowed under revolving credit line
    		                      0 0 0 480,000,000 190,000,000 250,000,000 215,000,000 495,000,000 220,000,000    0 0                                                     
      repayments of amounts borrowed under revolving credit line
    		                       -85,000,000 0 -695,000,000  -165,000,000 -180,000,000 -720,000,000                                                           
      proceeds from amounts borrowed under accounts receivable securitization agreement
    		                     16,000,000                                                                   
      non-cash interest expense
    		                      2,400,000 2,200,000 1,800,000 2,200,000 1,900,000 1,900,000 2,500,000 8,700,000 10,500,000 12,000,000 12,600,000 14,300,000 13,300,000 12,700,000 12,900,000 13,200,000 14,300,000 16,300,000 16,500,000 16,700,000 16,500,000 16,380,000 16,152,000 19,668,000 19,979,000 19,811,000               5,276,000 5,721,000 3,902,000 2,843,000 4,506,000 3,624,000 6,758,000 5,653,000 46,000 46,000 46,000 43,000               
      fair value write-up of inventory sold
    		                              17,400,000 19,900,000               0 0 22,521,000 29,876,000     0 0 1,961,000 1,337,000                               
      gain on sale of business
    		                               0                                                         
      proceeds from sale of business
    		                              0 0                                                         
      proceeds from sale of available-for-sale marketable securities
    		                          0 0 0 100,000 0 5,300,000                                                         
      repayment of amounts borrowed under revolving credit line
    		                                  0 -175,000,000                                                     
      proceeds from accounts receivable securitization program
    		                          5,200,000    0 40,000,000                                                         
      repayments under accounts receivable securitization program
    		                                                                                        
      payments under capital lease obligations
    		                      -400,000 -500,000 -400,000 -400,000 -400,000 -500,000 -400,000 -400,000 -500,000                                                          
      fair value write-up of acquired inventory sold
    		                       1,800,000 1,800,000 1,800,000                                                               
      repayment of amounts borrowed under accounts receivable securitization agreement
    		                                                                                        
      repayment of amounts borrowed under accounts receivable securitization program
    		                               -4,000,000 -32,000,000 -12,000,000                                                       
      gain on sale of investments
    		                                                                                        
      sales of mutual funds
    		                                  0 0   2,300,000 0 1,300,000 6,400,000 0 3,836,000 2,673,000 15,891,000                                           
      net gains on sale of marketable securities
    		                               0                                                         
      equity investment impairment charges
    		                                                                                        
      (gain) loss on sale of businesses
    		                                                                                        
      net proceeds from issuance of common stock pursuant to employee stock plans
    		                              6,500,000 15,900,000 13,400,000 13,200,000 11,100,000 8,400,000 7,900,000 11,100,000 19,600,000 13,000,000 22,200,000 15,200,000 5,600,000 22,082,000 40,812,000 12,906,000 23,880,000 13,597,000 24,846,000 12,777,000 6,853,000 1,352,000 18,762,000 1,627,000 1,326,000 10,670,000 10,464,000 2,944,000 1,300,000 1,071,000 8,317,000 1,906,000                           
      increase in other assets
    		                               -3,800,000 -900,000 -900,000 -600,000 -500,000 -800,000 900,000   300,000 -900,000 -400,000 -1,068,000 -1,503,000 -429,000 -3,014,000 417,000                  -3,101,000 1,473,000 -3,811,000 264,000 -4,291,000 3,929,000 -5,098,000 -157,000 -4,210,000 4,951,000 -3,128,000 -1,741,000 -847,000 -72,000 -62,000 -840,000 -198,000    32,000  37,000 
      gain on sale of available-for-sale marketable security
    		                                  0 0 0 -25,100,000                                                   
      changes in operating assets and liabilities:
    		                                                                                        
      proceeds from sale of available-for-sale marketable security
    		                                 400,000 0 0 0 31,100,000                                                   
      excess tax benefit related to equity awards
    		                                  -1,800,000 -1,300,000 -800,000 -7,100,000 -2,700,000 -2,000,000 -3,000,000 -3,000,000 -500,000 -1,066,000 -1,175,000 -2,959,000 -2,045,000 -957,000 -2,252,000 -2,185,000 -2,415,000 -1,108,000 -958,000 -1,725,000                                   
      asset impairment charges
    		                                          5,100,000 -8,000 30,176,000 3,132,000                                           
      loss on disposal of property and equipment
    		                                     1,300,000 2,100,000 1,300,000 1,500,000 1,700,000 2,000,000 1,662,000 2,027,000 1,411,000 1,252,000 1,475,000 1,292,000 906,000 1,407,000 1,089,000 940,000 373,000 819,000 525,000 570,000 725,000  684,000 495,000 1,124,000  543,000     239,000 57,000 290,000 432,000 -20,000 32,000 165,000 156,000 75,000 24,000           
      loss on sale of businesses
    		                                                                                        
      net (purchases) sales of insurance contracts
    		                                      0 0 0 -6,400,000                                               
      purchases of mutual funds
    		                                          0 32,000 0 -29,732,000                                           
      loss on sale of business
    		                                                                                        
      repurchase of convertible notes
    		                                     -100,000                                                   
      gain on sale of intellectual property
    		                                              0 0 0 -53,884,000 0 0   0 0                                 
      fair value adjustments to contingent consideration
    		                                              0 471,000 799,000 10,040,000 3,432,000 -13,276,000 43,188,000 5,122,000 -4,470,000 629,000                                 
      impairment of goodwill
    		                                                                                        
      payment of additional acquisition consideration
    		                                              0 0 0 -16,808,000 0 0 0 -9,784,000 0                                  
      proceeds from sale of intellectual property
    		                                              0 0 0 60,000,000 0 0   0 0 12,500,000 750,000 750,000 750,000 750,000 750,000 750,000 750,000   0                      
      (purchase) sale of a cost-method equity investment
    		                                                                                        
      repayment from revolving credit line
    		                                                                                        
      cost-method equity investment impairment charges
    		                                          0                                              
      loss on disposal of business
    		                                                                                        
      other
    		                                       -200,000 -500,000 1,200,000 -10,400,000 -656,000 222,000 -966,000 370,000 577,000 3,125,000 -1,149,000                                       
      net proceeds from long-term debt
    		                                                                                        
      acquired in-process research and development
    		                                                                                        
      gain on sale of cost-method equity investment
    		                                              0                                          
      changes in operating assets and liabilities, net of effects from acquisitions:
    		                                                                                        
      proceeds from sale of business, net of cash transferred
    		                                          7,700,000 -31,000 0 2,431,000 -1,116,000 0 84,762,000 1,488,000                                       
      net sales (purchases) of insurance contracts
    		                                          0 -41,000 0 13,841,000                                           
      acquisition of in-process research and development assets
    		                                                                                        
      purchase of cost-method equity investments
    		                                                                                        
      sale of a cost-method equity investment
    		                                                                                        
      acquisition of businesses
    		                                                                                        
      cost-method equity investment impairment
    		                                                                                        
      acquisition of a business
    		                                                                                        
      payment of debt issuance cost
    		                                                                                        
      purchase of cost method investments
    		                                                0 -3,625,000                                       
      payment of employee restricted stock minimum tax withholdings
    		                                             -9,054,000 -154,000 -2,130,000 -2,087,000 -7,885,000 -3,000 -11,000 -135,000 -5,561,000                                   
      impairment of intangible assets
    		                                                                                        
      cost method equity investment impairment
    		                                                                                        
      purchase of licensed technology and other intangible assets
    		                                                              1,176,000 -6,388,000 -88,000 -938,000                       
      sale of cost method investment
    		                                                                                        
      purchases of cost method investments
    		                                                                                        
      repayment of long-term debt and notes payable
    		                                                                                        
      cash and cash equivalents, beginning of year
    		                                                                                        
      cash and cash equivalents, end of year
    		                                                                                        
      intangible asset impairment
    		                                                                                        
      non-cash restructuring charges
    		                                               7,000   466,000 1,119,000                                     
      purchase of cost-method investments
    		                                                                                        
      sale of a cost-method investment
    		                                                                                        
      deferred acquisition consideration
    		                                                                                        
      non-cash interest expense – amortization of debt discount and deferred financing costs
    		                                                 20,679,000  16,001,000 18,921,000 19,960,000  19,198,000 18,694,000 19,471,000  23,753,000 22,053,000 21,073,000                           
      decrease in other assets
    		                                                 1,144,000                                       
      non-cash interest expense—amortization of debt discount and deferred financing costs
    		                                                                                        
      impairment of cost-method investments
    		                                                      0                                  
      (gain) loss on divestiture
    		                                                                                        
      other non-cash activity
    		                                                  -1,977,000 1,552,000 -1,318,000 -1,825,000 2,632,000 915,000 -1,458,000 -642,000 -379,000 -250,000 -401,000 2,038,000 -1,233,000 -1,085,000                         
      divestiture activities, net of cash transferred
    		                                                                                        
      proceeds from sale of cost method investment
    		                                                                  0    0 0                 
      increase in restricted cash
    		                                                                     -34,666,000                   
      loss on debt extinguishment
    		                                                                                        
      impairment of cost-method equity investment
    		                                                                                        
      changes in operating assets and liabilities, net of acquisitions:
    		                                                                                        
      divestiture of business, net of cash transferred to the buyer
    		                                                       0                                 
      purchase of other intangible assets
    		                                                       0    0 0 -500,000                           
      other assets
    		                                                                                        
      repayments of notes payable
    		                                                      -347,000 -342,000 -338,000 -335,000 -333,000 -327,000 -335,000 -1,842,000 -7,959,000    -541,000 -311,000 -1,753,000 -290,000                  -212,000 
      contingent consideration payments
    		                                                                                        
      loss on extinguishment of debt
    		                                                      0 0 0 29,891,000                               
      impairment of cost-method investment
    		                                                        0 2,100,000                               
      decrease in restricted cash
    		                                                    -8,000 9,000  -7,000 386,000 6,000  25,000 38,000 6,000  2,483,000                         
      acquisition of in process research and development assets
    		                                                                                        
      decrease (increase) in restricted cash
    		                                                                 483,000                       
      repayments under credit agreements
    		                                                                                        
      payments upon conversion of cytyc convertible notes
    		                                                                                        
      payments of employee restricted stock minimum tax withholdings
    		                                                                                        
      excess tax benefit related to exercise of non-qualified stock options
    		                                                       -1,501,000 -1,115,000 -652,000 -215,000 -338,000 -709,000 -781,000 -2,450,000 -229,000                         
      loss on divestiture
    		                                                          0 0                             
      proceeds from sale of cost-method investment
    		                                                                                        
      repayments under credit agreement
    		                                                           -46,969,000 -72,554,000 -54,644,000  -107,622,000 -58,643,000 -29,042,000  -89,647,000 -205,000,000 -2,055,353,000                   
      purchase of non-controlling interests
    		                                                           0 0 -2,683,000                           
      payment of employee restricted stock tax withholding requirements
    		                                                       -147,000 -6,234,000 -4,013,000  -116,000 -74,000 -2,332,000                           
      contingent consideration adjustment to fair value
    		                                                         1,096,000                               
      prepaid income tax
    		                                                         3,675,000   -143,000 172,000                           
      prepaid expenses and other current assets
    		                                                         -85,000   -2,978,000 -320,000    297,000 -4,560,000 -8,222,000 -1,588,000 4,404,000 1,017,000 -1,028,000 -3,943,000 -27,000 -2,136,000 6,622,000 -4,746,000 352,000 -3,266,000 -78,000 598,000 -313,000 542,000 368,000 -394,000 -72,000 -865,000 6,839,000 
      divestiture of business
    		                                                         1,129,000                               
      loss on disposal and impairment of property and equipment
    		                                                                                        
      deferred gain
    		                                                          0 0       0 2,000,000                     
      purchases of investment securities
    		                                                                  2,374,000 0 0 -2,637,000                   
      proceeds from sales and maturities of investment securities
    		                                                                  0 0 0 2,638,000                   
      proceeds from issuance of convertible notes, net of issuance costs
    		                                                                  0 0 -24,000 1,688,998,000                   
      proceeds under credit agreements, net of issuance costs
    		                                                                                        
      proceeds from note payable
    		                                                                                        
      financing costs on credit agreement
    		                                                              0 -36,000 -31,000 -283,000                       
      payments of employee restricted stock tax withholdings
    		                                                              -3,000                          
      fair value write-up of third wave inventory sold
    		                                                                                        
      charge for impairment of acquired intangible assets
    		                                                               0    0 0 2,900,000                   
      other-than-temporary impairment charge on cost-method investments
    		                                                                                        
      divestiture of business, net of cash transferred to buyer
    		                                                           0                             
      additional business acquisition consideration
    		                                                               0 97,000 -326,000                       
      payment upon conversion of cytyc convertible notes
    		                                                                   0                     
      other-than-temporary impairment charge on a cost-method investment
    		                                                                                        
      fair value write-up of cytyc and third wave inventory sold
    		                                                                                        
      impairment charges of intangibles
    		                                                                                        
      proceeds from sale of building
    		                                                                                        
      purchase of cost method investment
    		                                                              -150,000 -175,000                         
      acquisition of non-controlling interest
    		                                                                                        
      deferred acquisition costs
    		                                                                                        
      purchase of treasury shares to settle minimum withholding taxes
    		                                                                                        
      cash flows from operating activities:
    		                                                                                        
      fair value write-up of third wave and cytyc inventory
    		                                                               250,000                         
      charge for in-process research and development
    		                                                                   0 0 370,000,000     15,100,000 600,000 0 4,200,000           
      other-than-temporary impairment charges on cost-method investments
    		                                                                                        
      changes in assets and liabilities, net of acquisitions:
    		                                                                                        
      cash flows from investing activities:
    		                                                                                        
      merger with cytyc corporation, net of cash acquired
    		                                                                                        
      cash flows from financing activities:
    		                                                                                        
      proceeds under credit agreement, net of issuance costs
    		                                                                   0 -263,000 2,335,942,000                   
      proceeds from notes payable
    		                                                                                        
      net proceeds from sale of common stock pursuant to employee stock plans
    		                                                               347,000                         
      proceeds from sale of property and equipment
    		                                                                                        
      increase in notes payable
    		                                                                   0 172,000 2,055,000                   
      repayments of notes payable and capital leases
    		                                                                -1,283,000 -290,000                       
      supplemental disclosure of non-cash financing activities:
    		                                                                                        
      issuance of common stock upon conversion of cytyc convertible notes
    		                                                                     82,620,000                   
      business acquisition, net of cash acquired:
    		                                                                                        
      fair value of tangible assets acquired
    		                                                                                        
      fair value of liabilities assumed
    		                                                                                        
      fair value of stock issued
    		                                                                          -311,961,000              
      fair value of options exchanged
    		                                                                                        
      cost in excess of fair value of assets
    		                                                                                        
      fair value of acquired identifiable intangible assets
    		                                                                                        
      in-process research and development
    		                                                                                        
      deferred tax liability
    		                                                                                        
      less cash and cash equivalents and investments acquired
    		                                                                                        
      less acquisition costs paid prior to september 29, 2007
    		                                                                                        
      net cash paid for acquisition
    		                                                                          153,320,000         0     
      fair value write-up of cytyc and third wave inventory
    		                                                                 584,000                       
      non-cash interest income
    		                                                                 -70,000                       
      increase in unrecognized income tax benefits
    		                                                                 1,200,000                       
      tax benefit related to exercise of non-qualified stock options
    		                                                                 -78,000      -13,987,000 0 -2,244,000  1,116,000 22,310,000 -5,671,000           
      loss on disposal of property and equipment and intangible assets
    		                                                                 231,000 25,000                      
      income tax refundable
    		                                                                 17,748,000 20,257,000 795,000 34,165,000 19,191,000                   
      accrued expenses
    		                                                                 -24,763,000 -7,711,000 24,001,000 -1,008,000 -30,435,000 43,526,000 9,467,000 309,000 5,706,000 -4,939,000 692,000 18,723,000 24,000 -315,000 3,333,000 5,093,000 -2,139,000 2,864,000 -25,000 1,636,000 -976,000 766,000 -641,000 
      increase in other liabilities
    		                                                                 -164,000 -8,590,000 5,094,000 953,000 1,737,000                   
      net proceeds from sale of common stock pursuant to stock plans
    		                                                                 668,000 2,291,000 6,386,000 13,508,000 148,829,000 1,187,000 923,000 7,564,000 904,000 657,000 366,000 4,610,000 5,006,000 2,364,000          
      impairment charge on sale of intellectual property
    		                                                                                        
      tax benefit related to exercise of stock options
    		                                                                                        
      impairment charge on acquired intangibles
    		                                                                                        
      net cash paid for acquisition of intangible assets
    		                                                                          0 0 0 -27,594,000           
      acquisition of minority interest
    		                                                                                        
      increase in note payable
    		                                                                                        
      supplemental disclosure of cash flow information:
    		                                                                                        
      cash paid during the period for income taxes
    		                                                                     12,896,000 2,063,000 3,490,000 2,167,000 624,000 1,021,000 688,000 25,000 83,000 372,000 633,000 8,000 105,000 170,000 183,000 33,000 62,000 78,000 57,000 
      cash paid during the period for interest
    		                                                                     23,058,000 313,000 195,000 804,000 934,000 901,000 117,000 19,000 40,000 53,000 29,000 86,000 17,000 18,000 21,000 23,000 29,000 -29,000 71,000 
      supplemental disclosure of non-cash investing activities:
    		                                                                                        
      additional business acquisition contingent consideration
    		                                                                                        
      exchange of note receivable for intangible assets
    		                                                                          0 4,000 0 5,424,000           
      business acquisitions, net of cash acquired:
    		                                                                                        
      liabilities assumed
    		                                                                          -99,043,000         0     
      cost in excess of fair value of assets acquired
    		                                                                                        
      acquired identifiable intangible assets
    		                                                                                        
      less cash and cash equivalents acquired
    		                                                                                        
      net cash paid for business acquisition
    		                                                                                        
      fair value write-up of cytyc inventory
    		                                                                                        
      acquisition of cytyc corporation, net of cash acquired
    		                                                                   -2,000 -7,000 -2,022,338,000                   
      fair value write up of cytyc inventory
    		                                                                    825,000 41,500,000                   
      payment upon conversion of cytyc convertible note
    		                                                                     -38,334,000                   
      net cash from (used) in financing activities
    		                                                                     2,081,847,000                   
      net increase in cash and cash equivalent
    		                                                                     54,260,000                   
      tax benefit related to exercise of non qualified stock options
    		                                                                                        
      business acquisitions, net of cash acquired
    		                                                                                        
      additional acquisition contingent consideration
    		                                                                                        
      increase in deferred revenue
    		                                                                                        
      proceeds under credit facility
    		                                                                                        
      repayments under credit facility
    		                                                                                        
      in process research and development
    		                                                                          15,100,000              
      less cash acquired
    		                                                                          6,769,000              
      operating activities:
    		                                                                                        
      changes in assets and liabilities-
    		                                                                                        
      investing activities:
    		                                                                                        
      business acquisition, net of cash acquired
    		                                                                                        
      financing activities:
    		                                                                                        
      repayment under credit facility
    		                                                                       0 -40,000,000 -15,000,000               
      repayment under note payable
    		                                                                       1,133,000                 
      supplemental disclosure of noncash investing activities:
    		                                                                                        
      borrowing under note payable
    		                                                                                        
      repayment of note payable
    		                                                                         -1,406,000      -118,000 -119,000 -120,000  -157,000 -163,000 -177,000   
      net cash paid for acquisition of distributor
    		                                                                                  0 0     
      noncash interest expense
    		                                                                              31,000 30,000 41,000 31,000    31,000 21,000 55,000 
      increase in deferred tax asset related to exercise of non-qualified stock options
    		                                                                           -1,116,000             
      compensation expense related to issuance of equity awards
    		                                                                                        
      acquisition deposit
    		                                                                                        
      disposal of property and equipment
    		                                                                                        
      effect of exchange rate changes on cash
    		                                                                           -100,000 27,000 -72,000 -15,000 -343,000 -227,000 444,000 18,000 -13,000 437,000 -465,000 82,000 -42,000 
      fair value of tangibles assets acquired
    		                                                                                        
      purchase price payable
    		                                                                                        
      compensation expense related to issuance of stock options
    		                                                                            738,000 667,000           
      changes in assets and liabilities:
    		                                                                                        
      adjustments to reconcile net income to net cash from operating activities-
    		                                                                                        
      purchases of property and equipment
    		                                                                               -1,827,000 -1,579,000 -3,148,000  -1,583,000 -1,273,000 -1,419,000  -1,837,000 
      disposals of property and equipment
    		                                                                               123,000 355,000 229,000       
      net cash paid for acquisition:
    		                                                                                        
      fair value of assets acquired
    		                                                                                        
      costs in excess of net assets of distributor acquired
    		                                                                                   0     
      net proceeds from sale of common stock
    		                                                                                8,119,000 1,895,000 1,024,000 977,000 1,923,000 1,079,000 1,391,000 445,000 
      cash paid for acquisition
    		                                                                                        
      adjustments to reconcile net income to net cash from operating activities
    		                                                                                        
      loss on sale/leaseback
    		                                                                                        
      proceeds from sale/leaseback, net of costs
    		                                                                                        
      decrease (increase) in other assets
    		                                                                                  65,000 39,000     
      repayments of line of credit
    		                                                                                        
      issuance of note payable
    		                                                                                        
      supplemental disclosure of noncash financing activities:
    		                                                                                        
      stock issued for employee compensation
    		                                                                                        
      non cash interest expense
    		                                                                                        
      less: cash acquired
    		                                                                                        
      reversal of previously recorded trex reserves
    		                                                                                        
      compensation expense related to issuance of common stock and stock options
    		                                                                                        
      proceeds from settlement of trex purchase price
    		                                                                                        
      (repayments) borrowings under lines of credit
    		                                                                                        
      repayments of note payable
    		                                                                                        
      issuance of note payable to fleet business credit corp. for litigation settlement
    		                                                                                        
      repayments under line of credit
    		                                                                                        
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.